Pfizer's tofacitinib review backburnered for three months
Deborah Weinstein
August 21 2012
The drugmaker said Tuesday that, as expected, the FDA has delayed review of its rheumatoid arthritis medication.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.